New salesman for Leuze Electronic

Sensor firm appoints Midlands account manager

Andy Fereday has joined Leuze Electronic in St Neot’s, Cambridgeshire, UK as regional account manager for the Midlands.

Fereday has 20 years’ industrial experience and has spent the last seven years at Phoenix Contact selling automation and connectivity systems with which Leuze electronic’s sensors for detection and identification can integrate.

The company says the Midland region is an important market for its machine safety products, such as light-guards, light-curtains, safety laser scanners, machine interlocks and safety inspections.

‘The search to find a salesman with good local and strong industry knowledge took a long time,’ said Mark Weymouth, md of Leuze Electronic. ‘I’m very happy to have Andy joining the team, especially as he worked for me before.’

You may also like

Regulatory

Broughton receives flexible scope ISO 17025 accreditation

New certification allows accreditation without prior approval
Hi Tech Manufacturing

New chillers for laboratories

Expansion of the Minichiller range with more powerful models
Regulatory

Overcoming CMC challenges in cell and gene therapy: part II

Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
Regulatory

Overcoming CMC challenges in cell and gene therapy: part I

Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
Regulatory

AskBio receives FDA Fast Track Designation for congestive heart failure gene therapy programme

The fast-tracking allows the development and expedition of review processes for AB-1002, a gene therapy to promote production of a constituently active form of I-1c
Manufacturing

Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success

Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena
Regulatory

Isospec Analytics launches biomolecular analysis technology to identify unknown molecules

The novel technology optimises the identification process of unknown molecules compared to mass analysis
Subscribe now